#SFHS2608810VNotice on Decisions of the National Union of Health Insurance Funds Setting Insured Participation Rates for Pharmaceutical Specialties
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law updates the insured participation rate for a specific pharmaceutical product in France, setting it at 35%. It affects both patients who are prescribed this medication and pharmacies dispensing it. Consumers may see changes in out-of-pocket expenses.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- The insured participation rate is set at 35%
- Patients' out-of-pocket costs might change
- Pharmacies need to apply the new rate
Obligations
What this law requires
Apply a 35% insured participation rate to pharmaceutical product AMPHOTERIC.B LIPOS.MDH50MG F (UCD code 34008 900 518 7 3) when dispensing to patients
Ensure patient out-of-pocket cost reflects the 35% participation rate established by the National Union of Health Insurance Funds
Implement the updated participation rate as of the decision date (24 November 2025)